Skip to main content
ASKA Pharmaceutical Holdings Co., Ltd.ASKA Pharmaceutical Holdings Co., Ltd.
  • Contact Us
FONT SIZE
normal
large
LANGUAGE
JP
EN
  • HOME
    • About ASKA Pharmaceutical Holdings
      • Top Message
      • Corporate Philosophy
      • Company Overview
      • Charter of Corporate Behavior
      • Board Members and Corporate Officers
      • Group Companies
      • Business Activities
      • Corporate History
      • Organization Chart
      • Corporate Message
      • Digital Transformation
      • ASKA Pharmaceutical Holdings in Numbers
      • Policies
      • Access Map
    • For Our Shareholders and Investors
      • IR News
      • IR Library
      • IR Calendar
      • Management Strategies and Policies
      • Governance
      • Pipeline and Intellectual Property
      • Financial Highlights
      • ASKA Pharmaceutical Holdings at a glance
      • Stock Information
      • Disclaimer
      • IR E-mail Newsletter Service
      • IR Site Map
      • Recommended Route to Access Our IR Website
    • Sustainability
      • Our Sustainability
      • Environmental
      • Social
      • Governance
      • ESG Chart and ESG Data Book
      • External Evaluation
      • Initiatives and Member Organizations
      • Third-party Opinion
      • Sustainability News
      • Various Contrasting Tables
      • Policies
      • Integrated Report
    • Press Releases
    • Contact Us
    • Privacy Policy
    • Basic Policy on the Proper Handling of Specific Personal Information, etc.
    • Terms of Use
    • Site Policy
    • Cookie Policy
    • SNS コミュニティ・ガイドライン
    • 公式Webサイト・SNS
    • Sitemap
About ASKA Pharmaceutical Holdings
  • Company Overview
  • Group Companies
  • Top Message
  • Corporate Philosophy
  • Company Overview
  • Charter of Corporate Behavior
  • Board Members and Corporate Officers
  • Group Companies
  • Business Activities
  • Corporate History
  • Organization Chart
  • Corporate Message
  • Digital Transformation
  • ASKA Pharmaceutical Holdings in Numbers
  • Policies
  • Access Map
For Our Shareholders and Investors
  • Top Message
  • Medium-Term Management Plan
  • ASKA Pharmaceutical Holdings at a glance
  • IR News
  • IR Library
  • IR Calendar
  • Management Strategies and Policies
  • Governance
  • Pipeline and Intellectual Property
  • Financial Highlights
  • ASKA Pharmaceutical Holdings at a glance
  • Stock Information
  • Disclaimer
  • IR E-mail Newsletter Service
  • IR Site Map
  • Recommended Route to Access Our IR Website
Sustainability
  • Integrated Report
  • Our Basic Policy for Sustainability
  • Various Contrasting Tables
  • Our Sustainability
    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
  • Environmental Governance External Evaluation Third-party Opinion Various Contrasting Tables Integrated Report
  • Social ESG Chart and ESG Data Book Initiatives and Member Organizations Sustainability News Policies
HOME>HOME>For Our Shareholders and Investors>IR Calendar

IR Calendar

PRINT

This page contains the annual schedule of our company's IR-related events (financial results announcements, financial results meetings, ordinary general meetings of shareholders, dividend payments, etc.).
The months with events scheduled are indicated in red.

IR Events in FY2024

  • May 12 2025
    Financial Results for FY2024
  • February 3 2025
    Financial Results for 3Q FY2024
  • November 12 2024
    Financial Results Presentation for 2Q FY2024
  • November 5 2024
    Financial Results for 2Q FY2024
  • August 5 2024
    Financial Results for 1Q FY2024

IR Events in FY2023

  • May 22 2024
    Financial Results Presentation for FY2023
  • May 10 2024
    Financial Results for FY2023
  • February 5 2024
    Financial Results for 3Q FY2023
  • November 10 2023
    Financial Results Presentation for 2Q FY2023
  • November 6 2023
    Financial Results for 2Q FY2023
  • August 7 2023
    Financial Results for 1Q FY2023

 

Past IR Events(IR Library)

  • About ASKA Pharmaceutical Holdings
    • Top Message
    • Corporate Philosophy
    • Company Overview
    • Charter of Corporate Behavior
    • Board Members and Corporate Officers
    • Group Companies
    • Business Activities
    • Corporate History
    • Organization Chart
    • Corporate Message
    • Digital Transformation
    • ASKA Pharmaceutical Holdings in Numbers
    • Policies
    • Access Map
  • For Our Shareholders and Investors
    • IR News
    • IR Library
      • IR Library
      • Financial Results
      • Annual Securities Report
      • Integrated Report
      • Shareholder Newsletters (Japanese version only)
      • Shareholders' Meeting
      • Fact Sheet
    • IR Calendar
    • Management Strategies and Policies
      • Management Strategies and Policies
      • Top Message
      • Medium-Term Management Plan
      • Business Risks
      • Disclosure Policy
    • Governance
      • Governance
      • Basic Principles / Corporate Governance Structure
      • Corporate Governance Basic Policy
      • Corporate Governance Report (Japanese version only)
      • Board Members
      • Compliance / Risk Management
      • Internal Control System
      • Dialogue with Shareholders
      • Roundtable Discussion with Outside Directors
      • Material Issues: G
      • ESG Chart and ESG Data Book
    • Pipeline and Intellectual Property
    • Financial Highlights
      • Financial Highlights
      • Performance Review
      • Performance Highlights
      • Financial Conditions
      • Financial Statements
        • Consolidated Balance Sheets
        • Consolidated Statements of Income
        • Consolidated Statements of Cash Flows
      • Earnings Forecast
      • Non-Financial Highlights (ESG Chart and ESG Data Book)
    • ASKA Pharmaceutical Holdings at a glance
      • ASKA Pharmaceutical Holdings at a glance
      • Point1 About ASKA - Understanding & History -
      • Point2 About ASKA - Our Strengths -
      • Point3 Highly Specialized Product Lineup
      • Point4 Continuously Evolving R&D
      • Point5 Stable Shareholder Returns
      • Business Model
      • Frequently Asked Questions
    • Stock Information
      • Stock Information
      • Stock summary information
      • Shareholder Information
      • Shareholders' Meeting
      • Stock Price Information
      • Dividends and Dividend Payout Ratio
      • Articles of Incorporation and Stock Handling Regulations
      • Analyst Coverage
    • Disclaimer
    • IR E-mail Newsletter Service
    • IR Site Map
    • Recommended Route to Access Our IR Website
  • Sustainability
    • Our Sustainability
      • Our Sustainability
      • Top Commitment
      • Our Basic Policy for Sustainability
      • Materiality
      • Value Creation Process
      • Initiatives for Sustainability and SDGs
      • Importance of Female Healthcare and Social Issues
      • Disclosures based on TCFD recommendations
    • Environmental
      • Environmental
      • Environmental Management
      • Material Issues: E
      • Disclosures Based on TCFD Recommendations
      • Decarbonization Initiatives
      • Initiatives for Water Resource
      • Initiatives for Recycle-Oriented Society and Biodiversity
      • ESG Chart and ESG Data Book
    • Social
      • Social
      • Stakeholder Outcomes/Impact
      • Respect for Human Rights
      • Labour Practices
      • Diversity & Inclusion
      • Initiatives to Promote the Advancement of Women
      • Health Management Initiatives
      • Fair Operating Practices
      • Supply Chain
      • Customer Health and Safety
      • Social Contribution Activities(Community Involvement and Development)
      • Material Issues: S
      • ESG Chart and ESG Data Book
    • Governance
    • ESG Chart and ESG Data Book
    • External Evaluation
    • Initiatives and Member Organizations
    • Third-party Opinion
    • Sustainability News
    • Various Contrasting Tables
    • Policies
    • Integrated Report
  • Press Releases
  • Contact Us
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Site Policy
  • Cookie Policy
  • SNS コミュニティ・ガイドライン
  • 公式Webサイト・SNS
  • Sitemap
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Site Policy
  • Cookie Policy
  • Sitemap
Copyright © ASKA Pharmaceutical Holdings Co., Ltd. All Rights Reserved.
TOP